ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Gavreto 100 mg, Hartkapseln - 120
68182001 Blueprint Medicines (Switzerland) GmbH
Gavreto 100 mg, Hartkapseln12.08.2021
  12.08.2021
Other Protein Kinase Inhibitors (L01EX) 
WHO-DDD27.09.2025
07.16.10.120
07.16.10. 
A  
No 
IPCI
5969.33  
k.A.6432.35
  
7680681820017Synthetika
  
Composition
pralsetinibum 100 mg, hypromellosum, cellulosum microcristallinum, natrii hydrogenocarbonas corresp. natrium 22.3 mg, acidum citricum, magnesii stearas, amylum pregelificatum, Kapselhülle: hypromellosum, E 171, E 133, Drucktinte: lacca, propylenglycolum, ammonii hydroxidum, kalii hydroxidum, E 171, pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Pralsetinibum100 mg
BAG: Active AgentDose
Pralsetinibum100 mg
 
Inactive agents additional_information
Citric Acid  
Ammonii Hydroxidum  
Amylum Pregelificatum  
Cellulosum Microcristallinum  
E 133 color.
E 171 color.
Hypromellosum Kapselhülle
Kalii Hydroxidum  
Lacca Drucktinte
Magnesii Stearas  
Sodium Hydrogen Carbonate  
Pro Capsula  
Propylenglycol  
 
Source
Data was imported : 06.06.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home